VRDN — Viridian Therapeutics, Inc. stock price, charts and financials

QT41Viridian Therapeutics, Inc.

Viridian Therapeutics, Inc. (NASDAQ: VRDN) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
20.84
+1.53+7.92%
OverviewShort InterestFilings
VRDNQT41Viridian Therapeutics, Inc.·NASDAQ
20.84+7.92%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jul 02, 20264Statement of changes in beneficial ownership
Jul 02, 20264Statement of changes in beneficial ownership
Jul 02, 20264Statement of changes in beneficial ownership
Jul 02, 20264Statement of changes in beneficial ownership
Jul 02, 20264Statement of changes in beneficial ownership
Jul 02, 20264Statement of changes in beneficial ownership
Jun 29, 20268-KCurrent report
Jun 26, 2026SC 13GBeneficial ownership statement (passive)
Jun 03, 20268-KCurrent report
May 28, 20268-KCurrent report
May 26, 20268-KCurrent report
May 15, 2026SC 13GBeneficial ownership statement (passive)
May 13, 2026SC 13D/ABeneficial ownership statement (active, amended)
May 13, 20264Statement of changes in beneficial ownership
May 11, 20268-KCurrent report
May 08, 2026424B5Prospectus
May 08, 2026424B5Prospectus
May 08, 2026SC 13GBeneficial ownership statement (passive)
May 07, 2026305B2305B2
May 07, 2026FWPFree writing prospectus
May 07, 2026FWPFree writing prospectus
May 06, 2026424B5Prospectus
May 06, 2026424B5Prospectus
May 05, 20268-KCurrent report
May 05, 202610-QQuarterly report
#1 / 25 of 317
Page
▼
/ 13